nimodipine has been researched along with Chronic Primary Open Angle Glaucoma in 7 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To explore the curative effect of nimodipine combined with latanoprost in the treatment of open-angle glaucoma and its effect on ocular hemodynamics and visual field defects." | 1.72 | Efficacy of Nimodipine Combined with Latanoprost in Treating Open-Angle Glaucoma and Its Influence on Ocular Hemodynamics and Visual Field Defects. ( Duan, HP; Liu, R, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, HP | 1 |
| Liu, R | 1 |
| Michalk, F | 1 |
| Michelson, G | 1 |
| Harazny, J | 1 |
| Werner, U | 1 |
| Daniel, WG | 1 |
| Werner, D | 1 |
| Luksch, A | 1 |
| Rainer, G | 1 |
| Koyuncu, D | 1 |
| Ehrlich, P | 1 |
| Maca, T | 1 |
| Gschwandtner, ME | 1 |
| Vass, C | 1 |
| Schmetterer, L | 1 |
| Bose, S | 2 |
| Piltz, JR | 2 |
| Breton, ME | 1 |
| Cioffi, GA | 1 |
| Lanchoney, D | 1 |
| Grehn, F | 1 |
3 trials available for nimodipine and Chronic Primary Open Angle Glaucoma
| Article | Year |
|---|---|
Effect of nimodipine on ocular blood flow and colour contrast sensitivity in patients with normal tension glaucoma.
Topics: Administration, Oral; Calcium Channel Blockers; Choroid; Color Perception; Contrast Sensitivity; Cro | 2005 |
Nimodipine, a centrally active calcium antagonist, exerts a beneficial effect on contrast sensitivity in patients with normal-tension glaucoma and in control subjects.
Topics: Aged; Blood Pressure; Calcium Channel Blockers; Contrast Sensitivity; Cross-Over Studies; Double-Bli | 1995 |
The effect of nimodipine, a centrally active calcium antagonist, on visual function and mascular blood flow in patients with normal-tension glaucoma and control subjects.
Topics: Aged; Blood Flow Velocity; Blood Pressure; Calcium Channel Blockers; Color Perception; Cross-Over St | 1998 |
4 other studies available for nimodipine and Chronic Primary Open Angle Glaucoma
| Article | Year |
|---|---|
Efficacy of Nimodipine Combined with Latanoprost in Treating Open-Angle Glaucoma and Its Influence on Ocular Hemodynamics and Visual Field Defects.
Topics: Aged; Glaucoma, Open-Angle; Hemodynamics; Humans; Latanoprost; Middle Aged; Nimodipine; Ocular Hyper | 2022 |
Single-dose nimodipine normalizes impaired retinal circulation in normal tension glaucoma.
Topics: Blood Circulation; Blood Flow Velocity; Blood Pressure; Calcium Channel Blockers; Female; Glaucoma, | 2004 |
Three assumptions: ocular blood flow and glaucoma.
Topics: Blood Flow Velocity; Calcium Channel Blockers; Ciliary Arteries; Color Perception; Glaucoma, Open-An | 1998 |
[Prospects for neuroprotective glaucoma therapy].
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Apoptosis; | 2001 |